NIH supports interdisciplinary teams of three to six principal investigators pursuing an ambitious, shared scientific goal that cannot be achieved through individual efforts or separate projects.
The National Institutes of Health supports investigator-initiated, multidisciplinary research programs organized around a shared scientific theme, with clinical trials optional.
Large Collaborative Grant RFA supports Indiana University School of Medicine faculty collaborations, funding experiments that generate data for large, interdisciplinary grant proposals.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIH grant supports focused research projects requiring at least one clinical trial, aligning with the scientific interests of participating NIH Institutes and Centers.